642 related articles for article (PubMed ID: 18657586)
1. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia.
Kunz M; Gama CS; Andreazza AC; Salvador M; Ceresér KM; Gomes FA; Belmonte-de-Abreu PS; Berk M; Kapczinski F
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1677-81. PubMed ID: 18657586
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects.
Machado-Vieira R; Andreazza AC; Viale CI; Zanatto V; Cereser V; da Silva Vargas R; Kapczinski F; Portela LV; Souza DO; Salvador M; Gentil V
Neurosci Lett; 2007 Jun; 421(1):33-6. PubMed ID: 17548157
[TBL] [Abstract][Full Text] [Related]
3. Serum S100B and antioxidant enzymes in bipolar patients.
Andreazza AC; Cassini C; Rosa AR; Leite MC; de Almeida LM; Nardin P; Cunha AB; Ceresér KM; Santin A; Gottfried C; Salvador M; Kapczinski F; Gonçalves CA
J Psychiatr Res; 2007 Sep; 41(6):523-9. PubMed ID: 16956621
[TBL] [Abstract][Full Text] [Related]
4. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine.
Gama CS; Salvador M; Andreazza AC; Kapczinski F; Silva Belmonte-de-Abreu P
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):512-5. PubMed ID: 16426720
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress markers in bipolar disorder: a meta-analysis.
Andreazza AC; Kauer-Sant'anna M; Frey BN; Bond DJ; Kapczinski F; Young LT; Yatham LN
J Affect Disord; 2008 Dec; 111(2-3):135-44. PubMed ID: 18539338
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes.
Savas HA; Gergerlioglu HS; Armutcu F; Herken H; Yilmaz HR; Kocoglu E; Selek S; Tutkun H; Zoroglu SS; Akyol O
World J Biol Psychiatry; 2006; 7(1):51-5. PubMed ID: 16428220
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects.
Gubert C; Stertz L; Pfaffenseller B; Panizzutti BS; Rezin GT; Massuda R; Streck EL; Gama CS; Kapczinski F; Kunz M
J Psychiatr Res; 2013 Oct; 47(10):1396-402. PubMed ID: 23870796
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder.
Gama CS; Andreazza AC; Kunz M; Berk M; Belmonte-de-Abreu PS; Kapczinski F
Neurosci Lett; 2007 Jun; 420(1):45-8. PubMed ID: 17442489
[TBL] [Abstract][Full Text] [Related]
10. Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report.
Frey BN; Andreazza AC; Kunz M; Gomes FA; Quevedo J; Salvador M; Gonçalves CA; Kapczinski F
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):283-5. PubMed ID: 16859818
[TBL] [Abstract][Full Text] [Related]
11. Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment.
Gergerlioglu HS; Savas HA; Bulbul F; Selek S; Uz E; Yumru M
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):697-702. PubMed ID: 17303295
[TBL] [Abstract][Full Text] [Related]
12. Reduced antioxidant defense systems in schizophrenia and bipolar I disorder.
Raffa M; Barhoumi S; Atig F; Fendri C; Kerkeni A; Mechri A
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):371-5. PubMed ID: 22841966
[TBL] [Abstract][Full Text] [Related]
13. Altered antioxidant defense system in clinically stable patients with schizophrenia and their unaffected siblings.
Ben Othmen L; Mechri A; Fendri C; Bost M; Chazot G; Gaha L; Kerkeni A
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):155-9. PubMed ID: 17804133
[TBL] [Abstract][Full Text] [Related]
14. Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder.
Kuloglu M; Ustundag B; Atmaca M; Canatan H; Tezcan AE; Cinkilinc N
Cell Biochem Funct; 2002 Jun; 20(2):171-5. PubMed ID: 11979513
[TBL] [Abstract][Full Text] [Related]
15. Thiobarbituric Acid-Reactive Substances: Markers of an Acute Episode and a Late Stage of Bipolar Disorder.
Siwek M; Sowa-Kucma M; Styczen K; Misztak P; Szewczyk B; Topor-Madry R; Nowak G; Dudek D; Rybakowski JK
Neuropsychobiology; 2016; 73(2):116-22. PubMed ID: 27023678
[TBL] [Abstract][Full Text] [Related]
16. The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode.
Selek S; Savas HA; Gergerlioglu HS; Bulbul F; Uz E; Yumru M
J Affect Disord; 2008 Apr; 107(1-3):89-94. PubMed ID: 17869345
[TBL] [Abstract][Full Text] [Related]
17. Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders.
Monteleone P; Serritella C; Martiadis V; Maj M
Bipolar Disord; 2008 Feb; 10(1):95-100. PubMed ID: 18199246
[TBL] [Abstract][Full Text] [Related]
18. Thiobarbituric acid reactive substances (TBARS) is a state biomarker of oxidative stress in bipolar patients in a manic phase.
Tsai MC; Huang TL
J Affect Disord; 2015 Mar; 173():22-6. PubMed ID: 25462391
[TBL] [Abstract][Full Text] [Related]
19. Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder.
Rosa AR; Frey BN; Andreazza AC; Ceresér KM; Cunha AB; Quevedo J; Santin A; Gottfried C; Gonçalves CA; Vieta E; Kapczinski F
Neurosci Lett; 2006 Oct; 407(2):146-50. PubMed ID: 16959421
[TBL] [Abstract][Full Text] [Related]
20. Peripheral markers of oxidative stress and antioxidative defense in euthymia of bipolar disorder--Gender and obesity effects.
Bengesser SA; Lackner N; Birner A; Fellendorf FT; Platzer M; Mitteregger A; Unterweger R; Reininghaus B; Mangge H; Wallner-Liebmann SJ; Zelzer S; Fuchs D; McIntyre RS; Kapfhammer HP; Reininghaus EZ
J Affect Disord; 2015 Feb; 172():367-74. PubMed ID: 25451439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
